Hypoxic pulmonary vasoconstriction in cardiothoracic surgery: basic mechanisms to potential therapies

This publication has 80 references indexed in Scilit:

• Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor
  Published by Elsevier ,2004
• Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
  The Lancet, 2001
• Impairment of hypoxic pulmonary vasoconstriction in mice lacking the voltage‐gated potassium channel Kv1.5
  The FASEB Journal, 2001
• Voltage‐independent calcium entry in hypoxic pulmonary vasoconstriction of intrapulmonary arteries of the rat
  The Journal of Physiology, 2000
• Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease
  The American Journal of Cardiology, 1996
• Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome
  New England Journal of Medicine, 1993
• Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.
  Heart, 1993
• Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia
  Biochemical and Biophysical Research Communications, 1990
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
  Nature, 1980
• Pulmonary hypertension in the adult respiratory distress syndrome (ARDS)
  Intensive Care Medicine, 1979